Dumont & Blake Investment Advisors LLC Amarin Corp Plcuk Transaction History

Dumont & Blake Investment Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$1.13 - $3.69 $1,130 - $3,690	1,000 Added 4.55%	23,000 $34,000
Q2 2019 Aug 01, 2019	SELL	$16.27 - $20.51 $26,032 - $32,816	-1,600 Reduced 6.78%	22,000 $427,000
Q4 2018 Feb 07, 2019	BUY	$12.41 - $22.98 $6,205 - $11,490	500 Added 2.16%	23,600 $321,000
Q3 2018 Oct 19, 2018	BUY	$2.45 - $16.27 $245 - $1,627	100 Added 0.43%	23,100 $376,000
Q3 2017 Oct 31, 2017	BUY	$3.03 - $3.72 $69,690 - $85,560	23,000	23,000 $80,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Dumont & Blake Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Dumont & Blake Investment Advisors LLC with notifications on news.